Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Accumulated Expenses (2016 - 2025)

Palisade Bio has reported Accumulated Expenses over the past 15 years, most recently at $1.3 million for Q4 2025.

  • Quarterly Accumulated Expenses rose 4.68% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 4.68% year-over-year, with the annual reading at $1.3 million for FY2025, 4.68% up from the prior year.
  • Accumulated Expenses was $1.3 million for Q4 2025 at Palisade Bio, up from $621000.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.7 million in Q1 2024 and troughed at $118000.0 in Q1 2025.
  • The 5-year median for Accumulated Expenses is $551500.0 (2022), against an average of $638563.0.
  • Year-over-year, Accumulated Expenses surged 774.35% in 2024 and then crashed 92.93% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $463000.0 in 2021, then rose by 23.97% to $574000.0 in 2022, then soared by 44.77% to $831000.0 in 2023, then surged by 49.22% to $1.2 million in 2024, then rose by 4.68% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Accumulated Expenses are $1.3 million (Q4 2025), $621000.0 (Q3 2025), and $192000.0 (Q2 2025).